FLUDAMAX
Description
Fludarabine is a purine analogue that has replaced traditional alkylating agent based standard initial treatment of Chronic Lymphocytic Leukemia (CLL) owing to higher response rates and greater survival advantage.
Indications:
- FLUDAMAX for injection is indicated for the treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL) who have not responded to or whose disease has progressed during treatment with at least one standard alkylating-agent containing regimen
| Generic Name | Strength | Standard | Type | Packing | Pack Size |
| Fludarabine | 50 mg | USP | INJ | Vial | ml |